CLINICAL_TRIALS
research
· 2025-05-16
Clinical Trial Update: Pharmacoscopy-guided Clinical Standard-of-care in r/r AML [Phase 2]
Summary
Phase 2 trial evaluating pharmacoscopy-guided standard-of-care for relapsed/refractory acute myeloid leukemia is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: ETH Zurich | Conditions: AML, Adult | Phase 2 | Status: RECRUITING